2 ML iron-dextran complex 50 MG/ML Injection [InFed] — RxCUI 206216
RxNorm drug concept · Semantic branded drug
RxCUI 206216
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI206216
Official name2 ML iron-dextran complex 50 MG/ML Injection [InFed]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as2 ML InFed 50 MG/ML Injection; INFeD 100 MG in 2 ML Injection; INFeD 100 MG per 2 ML Injection
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)34,405 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Iron Dextran Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- INFeD is specifically for people whose iron deficiency can't be managed with oral iron — either because pills upset your stomach too much or because your body hasn't responded to t...
- Why do I need an injection instead of just taking iron pills?
- Before your first full treatment dose, you'll receive a very small amount of INFeD — called a test dose — and then be watched for at least an hour. This is because some people have...
- What is the test dose, and why do I need it?
🕸️ Concept Web — How 2 ML iron-dextran complex 50 MG/ML Injection [In... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
2 ML iron-dextran complex 50 MG/ML Injection [InFed]
RxCUI 206216 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Iron-dextran complex
5992IN
-
Iron-dextran complex
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
InFed
217731BN
-
InFed
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Iron-dextran complex Injection
1865657SCDF -
Iron-dextran complex Injectable Product
1159148SCDG -
Iron-dextran complex Injection [InFed]
1865659SBDF -
InFed Injectable Product
1172008SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Iron-dextran complex Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
2 ML iron-dextran complex 50 MG/ML Injection
311144SCD -
Iron-dextran complex 50 MG/ML
316103SCDC -
Iron-dextran complex 50 MG/ML [InFed]
567078SBDC
-
2 ML iron-dextran complex 50 MG/ML Injection
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
2 ML iron-dextran complex 50 MG/ML Injection
SCD · 311144 -
Iron-dextran complex 50 MG/ML
SCDC · 316103 -
Iron-dextran complex Injection
SCDF · 1865657 -
Iron-dextran complex Injectable Product
SCDG · 1159148
Brand-Name Concepts
-
Iron-dextran complex 50 MG/ML [InFed]
SBDC · 567078 -
Iron-dextran complex Injection [InFed]
SBDF · 1865659 -
InFed Injectable Product
SBDG · 1172008 -
InFed
BN · 217731
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 206216 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00023-6082-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0023-6082-10) / 2 mL in 1... | INFeD | Allergan, Inc. | 1974-04-29 |
| 00404-9879-02 | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9879-02) / 2 mL in 1 VIA... | INFED | Henry Schein, Inc. | 2022-01-11 |
Observed labelers:
Allergan, Inc. (1) ·
Henry Schein, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$18.9002
Range $18.9002–$18.9002
· middle 50% $18.9002–$18.9002
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1750 | Inj iron dextran | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.